BO

Unknown

524 clinical trials

Find Trials

Clinical Trials (524)

Showing 20 of 524 trialsScroll for more
NCT03048422Phase 32 sites

Evaluating the Efficacy and Safety of Dolutegravir-Containing Versus Efavirenz-Containing Antiretroviral Therapy Regimens in HIV-1-Infected Pregnant Women and Their Infants

Completed
NCT05986084Phase 41 site

Tshireletso: Safety, Efficacy and Feasibility of Cabotegravir-LA PrEP in a Breastfeeding Population in Botswana

Active Not Recruiting
NCT06134362Phase 31 site

Long-term Follow-up of Long-acting Cabotegravir (CAB LA) for PrEP (Pre-exposure Prophylaxis) in Participants at Risk of Acquiring HIV (Human Immunodeficiency Virus)

Active Not Recruiting
NCT07032662Phase 24 sites

Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Recruiting
NCT05645107Phase 33 sites

A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma

Recruiting
NCT05197049Phase 36 sites

A Study of Guselkumab Subcutaneous Therapy in Participants With Moderately to Severely Active Crohn's Disease

Active Not Recruiting
NCT05588323Phase 11 site

Safety and Pharmacokinetics Study of Naldemedine in Paediatric Participants Receiving Opioids

Recruiting
NCT07012395Phase 23 sites

A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

Recruiting
NCT07633288Phase 23 sites

A Clinical Trial Evaluating the Safety and Efficacy of AP1189 Versus Placebo as an add-on to Standard of Care in Participants With Respiratory Insufficiency Expected to be Caused by Infection With Respiratory Viruses

Recruiting
NCT03523858Phase 34 sites

A Study to Evaluate Ocrelizumab Treatment in Participants With Progressive Multiple Sclerosis

Active Not Recruiting
NCT05952141Not Applicable2 sites

Strategies to Close the Gap From Cervical Cancer Diagnosis to Treatment in Botswana

Recruiting
NCT06192160Phase 21 site

Trial of Novel Regimens for the Treatment of Pulmonary Tuberculosis

Recruiting

Pharmacokinetic Study of Long-acting Antiretrovirals and Contraceptives in HIV

Not Yet Recruiting
NCT07503873Phase 24 sites

A Study to Evaluate Pharmacokinetics (PK) and Safety of Subcutaneous (SC) Ublituximab Administered at Various Injection Sites and Relative Bioavailability Via Autoinjector (AI) Versus Syringe Subcutaneously in Participants With Multiple Sclerosis (MS)

Recruiting
NCT06226883Phase 23 sites

A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

Recruiting
NCT07211633Phase 35 sites

A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, Radiological and Clinical Effects of Subcutaneous Ublituximab in Participants With Relapsing Multiple Sclerosis (RMS)

Active Not Recruiting
NCT06468228Phase 34 sites

A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa

Active Not Recruiting
NCT07226492Not Applicable8 sites

Cash Transfers to Pregnant Women With HIV

Recruiting
NCT03456076Phase 31 site

A Study Comparing Adjuvant Alectinib Versus Adjuvant Platinum-Based Chemotherapy in Patients With ALK Positive Non-Small Cell Lung Cancer

Active Not Recruiting
NCT06705478Phase 21 site

Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disorder (MND) in Persons With HIV

Suspended